Public Health & Access
HIV prevention uptake rises but coverage gaps remain
By Intent.Health Team • May 5, 2026
What’s happening
Use of Gilead’s HIV prevention shot is rising in the U.S., but insurance coverage gaps continue to limit broader adoption.
What’s changing / Business impact
-
Growth in: preventive care demand.
-
Opportunity for: HIV drugmakers.
-
Pressure on: insurers to expand coverage.
Why this matters
Preventive healthcare adoption is increasing.
Access remains constrained by payer systems.